GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Lifesciences | Medical Devices & Consumables

GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027

Market By Drugs & Devices And Geography | Forecast 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

The Triton Market Research report on the global ophthalmology drugs and devices market depicts that the market will display an upward trend in terms of revenue and is estimated to flourish with CAGR of 6.16% over the forecasting years of 2019-2027. The market was assessed to be worth $61957.65 million in the year 2018 and is predicted to generate a revenue of approximately $106099.61 million by the year 2027.

Report scope can be customized per your requirements. Request For Customization

Ophthalmology is a field of medicine dealing with the anatomy, physiology and diseases of the eyeball and the orbit. An ophthalmologist is a specialist doctor who treats medical and surgical eye-related conditions. Ophthalmology also includes sub-specialities that deal either with certain sickness as a whole or diseases concerning certain parts of the eye. 

Within the Triton report, the study of the market has been detailed by highlighting it within the key components for a clear understanding of every aspect that influences the global market. The report consists of a strategic outlook, key insights, value chain outlook, key buying standards, investment outlook, supply chain outlook, regulatory outlook and Porter’s five force analysis. 

The market drivers like increasing elderly population, surge in ophthalmic disorders due to high blood sugar, rise in healthcare spending and other technological advancements are responsible for boosting the market ahead. On the other hand, expirations of brand patents, which affect the pharmaceutical industry, low cognizance related to ophthalmic drugs and delay in drug approval are known to obstruct the industry growth significantly.

Key opportunities such as the increasing demand for phacoemulsification devices and intraocular lenses and the rising opportunities for these drugs from the emerging countries are set to leverage the growth prospects for the market over the projected years. Still, challenges such as difficulties associated with the conduct of ocular diseases remain unsolved, which threatens the further growth of the market.

To get detailed insights on segments, Download Sample Report

The prime geographies that have been covered in the Triton’s ophthalmology drugs and devices market are:

•    North America: The United States and Canada

•    Europe: The United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe

•    Asia-Pacific: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia-Pacific

•   Latin America: Brazil, Mexico and Rest of Latin America

•    The Middle East and Africa: The United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East & Africa

Global ophthalmology drugs and devices market segmentation:

The ophthalmology drugs and devices market report has been segmented into drugs and devices.

•    Devices:

O    Diagnostic and Monitoring Equipment

•    Optical Coherence Tomography

•    Ophthalmic Ultrasound Imaging Systems

•    Fundus Camera Market

•    Ophthalmoscope

•    Retinoscope

•    Pachymeter

•    Wavefront Aberrometers

•    Perimeters/Visual Field Analyzer

•    Autorefractors/Phoropter

•    Specular Microscope

•    Corneal Topographers

•    Other Diagnostic and Monitoring Equipment

O    Surgery Devices

•    Cataract Surgery Devices

•    Glaucoma Surgery Devices

•    Refractive Surgery Devices

•    Vitreoretinal Surgery Devices

O    Vision Care

•    Drugs: 

O    Glaucoma Drug

O    Retinal Disorder Drug

O    Dry Eye Drug

O    Allergic Conjunctivitis, Inflammation And Conjunctivitis Drug

O    Drugs by use of Preservation

•    Preserved Drugs

•    Preservative-free Drugs

The major players in the ophthalmology drugs and devices market are Allergan, Inc., Bayer, Carl Zeiss AG, Essilor International S.A., GlaxoSmithKline, Johnson & Johnson, Inc., Novartis International AG, Pfizer, Roche Holding AG, Santen Pharmaceutical Co., Ltd., Sun Pharmaceuticals Industries, Ltd., Valeant Pharmaceuticals International, Inc. and Ziemer Group Holding AG.

Each of these companies has been studied in detail for the ophthalmology drugs and devices market report. The market share of the above-mentioned companies is detailed in the competitive analysis chapter to provide information about the market positioning and to determine their hold on the market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. PORTER’S FIVE FORCES ANALYSIS

2.2.1.   BARGAINING POWER OF BUYERS

2.2.2.   BARGAINING POWER OF SUPPLIER

2.2.3.   THREATS OF NEW ENTRANTS

2.2.4.   THREATS OF SUBSTITUTES

2.2.5.   COMPETITIVE RIVALRY

2.3. STRATEGIC OUTLOOK

2.4. MARKET SHARE OUTLOOK

2.5. KEY INSIGHT

2.6. VALUE CHAIN OUTLOOK

2.7. KEY BUYING STANDARDS

2.8. INVESTMENT OUTLOOK

2.9. SUPPLY CHAIN OUTLOOK

2.10.            REGULATORY FRAMEWORK

2.11.            MARKET DRIVERS

2.11.1.                ELDERLY POPULATION IS INCREASING WORLDWIDE

2.11.2.                INCREASING OPHTHALMIC DISORDERS DUE TO HIGH BLOOD SUGAR

2.11.3.                UPSURGE IN HEALTHCARE SPENDING

2.11.4.                TECHNOLOGICAL ADVANCEMENT

2.12.            MARKET RESTRAINTS

2.12.1.                EXPIRATIONS OF BRAND PATENTS HAVE AFFECTED THE PHARMACEUTICAL INDUSTRY

2.12.2.                LOW COGNIZANCE RELATED TO OPHTHALMIC DRUGS

2.12.3.                DRUG APPROVALS DELAY AND NUMBER OF DRUGS IN THE PIPELINE

2.13.            MARKET OPPORTUNITIES

2.13.1.                INCREASING DEMAND FOR PHACOEMULSIFICATION DEVICES AND INTRAOCULAR LENSES

2.13.2.                RISING OPPORTUNITIES IN THE DEVELOPING COUNTRIES

2.14.            MARKET CHALLENGES

2.14.1.                DIFFICULTIES ASSOCIATED WITH THE CONDUCT OF OCULAR DISEASES

3.    OPTHALMOLOGY DRUGS AND DEVICES MARKET OUTLOOK - BY DRUGS AND DEVICES

3.1. DEVICES

3.1.1.   DIAGNOSTIC & MONITORING EQUIPMENT

3.1.1.1.      OPTICAL COHERENCE TOMOGRAPHY

3.1.1.2.      OPHTHALMIC ULTRASOUND IMAGING SYSTEMS

3.1.1.3.      FUNDUS CAMERA MARKET

3.1.1.4.      OPHTHALMOSCOPES

3.1.1.5.      RETINOSCOPE

3.1.1.6.      PACHYMETER

3.1.1.7.      WAVEFRONT ABERROMETERS

3.1.1.8.      PERIMETERS/VISUAL FIELD ANALYZER

3.1.1.9.      AUTOREFRACTORS/PHOROPTER

3.1.1.10.   SPECULAR MICROSCOPE

3.1.1.11.   CORNEAL TOPOGRAPHERS

3.1.1.12.   OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET

3.1.2.   SURGERY DEVICE

3.1.2.1.      CATARACT SURGERY DEVICES

3.1.2.2.      GLAUCOMA SURGERY DEVICES

3.1.2.3.      REFRACTIVE SURGERY DEVICES

3.1.2.4.      VITREORETINAL SURGERY DEVICES

3.1.3.   VISION CARE

3.2. DRUGS

3.2.1.   GLAUCOMA DRUG

3.2.2.   RETINAL DISORDER DRUG

3.2.3.   DRY EYE DRUG

3.2.4.   ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG

3.2.5.   DRUGS BY USE OF PRESERVATION

3.2.5.1.      PRESERVED DRUGS

3.2.5.2.      PRESERVATIVE-FREE DRUGS

4.    OPTHALMOLOGY DRUGS AND DEVICES MARKET - REGIONAL OUTLOOK

4.1. NORTH AMERICA

4.1.1.   MARKET BY DRUGS AND DEVICES

4.1.1.1.      MARKET BY DEVICES

4.1.1.2.      MARKET BY DRUGS

4.1.2.   COUNTRY ANALYSIS

4.1.2.1.      THE UNITED STATES

4.1.2.2.      CANADA

4.2. EUROPE

4.2.1.   MARKET BY DRUGS AND DEVICES

4.2.1.1.      MARKET BY DEVICES

4.2.1.2.      MARKET BY DRUGS

4.2.2.   COUNTRY ANALYSIS

4.2.2.1.      THE UNITED KINGDOM

4.2.2.2.      FRANCE

4.2.2.3.      GERMANY

4.2.2.4.      SPAIN

4.2.2.5.      ITALY

4.2.2.6.      RUSSIA

4.2.2.7.      REST OF EUROPE

4.3. ASIA-PACIFIC

4.3.1.   MARKET BY DRUGS AND DEVICES

4.3.1.1.      MARKET BY DEVICES

4.3.1.2.      MARKET BY DRUGS

4.3.2.   COUNTRY ANALYSIS

4.3.2.1.      INDIA

4.3.2.2.      CHINA

4.3.2.3.      JAPAN

4.3.2.4.      SOUTH KOREA

4.3.2.5.      AUSTRALIA & NEW ZEALAND

4.3.2.6.      ASEAN COUNTRIES

4.3.2.7.      REST OF APAC

4.4. LATIN AMERICA

4.4.1.   MARKET BY DRUGS AND DEVICES

4.4.1.1.      MARKET BY DEVICES

4.4.1.2.      MARKET BY DRUGS

4.4.2.   COUNTRY ANALYSIS

4.4.2.1.      BRAZIL

4.4.2.2.      MEXICO

4.4.2.3.      REST OF LATIN AMERICA

4.5. MIDDLE EAST AND AFRICA

4.5.1.   MARKET BY DRUGS AND DEVICES

4.5.1.1.      MARKET BY DEVICES

4.5.1.2.      MARKET BY DRUGS

4.5.2.   COUNTRY ANALYSIS

4.5.2.1.      SAUDI ARABIA

4.5.2.2.      TURKEY

4.5.2.3.      UNITED ARAB EMIRATES

4.5.2.4.      SOUTH AFRICA

4.5.2.5.      REST OF MIDDLE EAST & AFRICA

5.    COMPETITIVE LANDSCAPE

5.1. ALLERGAN, INC.

5.2. BAYER

5.3. CARL ZEISS AG

5.4. ESSILOR INTERNATIONAL S.A.

5.5. GLAXOSMITHKLINE

5.6. JOHNSON & JOHNSON, INC.

5.7. NOVARTIS INTERNATIONAL AG

5.8. PFIZER

5.9. ROCHE HOLDING AG

5.10.            SANTEN PHARMACEUTICAL CO., LTD.

5.11.            SUN PHARMACEUTICALS INDUSTRIES, LTD.

5.12.            VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

5.13.            ZIEMER GROUP HOLDING AG

6.    METHODOLOGY AND SCOPE

6.1. RESEARCH SCOPE

6.2. SOURCES OF DATA

6.3. RESEARCH METHODOLOGY

List of table

TABLE LIST

TABLE 1        GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)      

TABLE 2        COMMON CAUSES OF LOSS OF VISION IN THE ELDERLY         

TABLE 3        SELECTED LIST OF GLAUCOMA DRUGS IN LATE-STAGE CLINICAL TRIALS 

TABLE 4        EYE DRUGS GONE OFF-PATENT         

TABLE 5        GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)          

TABLE 6        GLOBAL DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT BY TYPES 2019-2027 ($ MILLION)   

TABLE 7        GLOBAL DEVICES MARKET IN SURGERY DEVICE BY TYPES 2019-2027 ($ MILLION)      

TABLE 8        GLOBAL DRUGS AND DEVICES MARKET IN DRUGS BY TYPES 2019-2027 ($ MILLION)      

TABLE 9        GLOBAL DRUGS MARKET IN DRUGS BY USE OF PRESERVATION 2019-2027 ($ MILLION)      

TABLE 10      GLOBAL DRUGS BY USE OF PRESERVATION IN PRESERVATIVE FREE DRUGS BY DOSES 2019-2027 ($ MILLION)        

TABLE 11      GLOBAL DRUGS BY USE OF PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)     

TABLE 12      GLOBAL OPHTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)      

TABLE 13      NORTH AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)         

TABLE 14      NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)    

TABLE 15      EUROPE OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)          

TABLE 16      EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)     

TABLE 17      ASIA-PACIFIC OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION) 

TABLE 18      ASIA-PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)    

TABLE 19      LATIN AMERICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION) 

TABLE 20      LATIN AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)    

TABLE 21      MIDDLE EAST AND AFRICA OPHTHALMOLOGY DRUGS AND DEVICES MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)   

TABLE 22      MIDDLE EAST AND AFRICA OPTHALMOLOGY DRUGS AND DEVICES MARKET BY COUNTRIES 2019-2027 ($ MILLION)           

List of Figures

FIGURE 1      GLOBAL OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 2      GLOBAL OPHTHALMOLOGY DEVICES COMPANY MARKET SHARE 2018 (%)                        

FIGURE 3      GLOBAL OPHTHALMOLOGY DRUGS COMPANY MARKET SHARE 2018 (%)                           

FIGURE 4      THE POPULATION OF PEOPLE AGED 65 AND OVER WILL DOUBLE IN THE NEXT 25 YEARS (IN MILLION)                           

FIGURE 5      PROJECTIONS FOR THE PROPORTION OF GERIATRIC (60+) POPULATION IN 2015, 2030 & 2050

FIGURE 6      PREVALENCE OF DIABETES BY AGE GROUP (IN MILLION)                    

FIGURE 7      GLOBAL DRUGS AND DEVICES MARKET IN DEVICES 2019-2027 ($ MILLION)                                   

FIGURE 8      GLOBAL DEVICES MARKET IN DIAGNOSTIC & MONITORING EQUIPMENT 2019-2027 ($ MILLION)                           

FIGURE 9      GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPTICAL COHERENCE TOMOGRAPHY 2019-2027 ($ MILLION)                                

FIGURE 10   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMIC ULTRASOUND IMAGING SYSTEMS 2019-2027 ($ MILLION)                      

FIGURE 11   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN FUNDUS CAMERA MARKET 2019-2027 ($ MILLION)                             

FIGURE 12   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OPHTHALMOSCOPES 2019-2027 ($ MILLION)                                  

FIGURE 13   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN RETINOSCOPE 2019-2027 ($ MILLION)                             

FIGURE 14   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PACHYMETER 2019-2027 ($ MILLION)                             

FIGURE 15   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN WAVEFRONT ABERROMETERS 2019-2027 ($ MILLION)                              

FIGURE 16   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN PERIMETERS/VISUAL FIELD ANALYZER 2019-2027 ($ MILLION)                        

FIGURE 17   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN AUTOREFRACTORS/PHOROPTER 2019-2027 ($ MILLION)                                   

FIGURE 18   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN SPECULAR MICROSCOPE 2019-2027 ($ MILLION)                         

FIGURE 19   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN CORNEAL TOPOGRAPHERS 2019-2027 ($ MILLION)                              

FIGURE 20   GLOBAL DIAGNOSTIC & MONITORING EQUIPMENT MARKET IN OTHER DIAGNOSTIC & MONITORING EQUIPMENT MARKET 2019-2027 ($ MILLION)                          

FIGURE 21   GLOBAL DEVICES MARKET IN SURGERY DEVICE 2019-2027 ($ MILLION)                              

FIGURE 22   GLOBAL SURGERY DEVICES MARKET IN CATARACT SURGERY DEVICES 2019-2027 ($ MILLION)                           

FIGURE 23   GLOBAL SURGERY DEVICES MARKET IN GLAUCOMA SURGERY DEVICES 2019-2027 ($ MILLION)                             

FIGURE 24   GLOBAL SURGERY DEVICES MARKET IN REFRACTIVE SURGERY DEVICES 2019-2027 ($ MILLION)                             

FIGURE 25   GLOBAL SURGERY DEVICES MARKET IN VITREORETINAL SURGERY DEVICES 2019-2027 ($ MILLION)                             

FIGURE 26   GLOBAL DEVICES MARKET IN VISION CARE MARKET 2019-2027 ($ MILLION)                                   

FIGURE 27   GLOBAL DRUGS AND DEVICES MARKET IN DRUGS 2019-2027 ($ MILLION)                          

FIGURE 28   GLOBAL DRUGS MARKET IN GLAUCOMA DRUG 2019-2027 ($ MILLION)                                 

FIGURE 29   GLOBAL DRUGS MARKET IN RETINAL DISORDER DRUG 2019-2027 ($ MILLION)                                   

FIGURE 30   GLOBAL DRUGS MARKET IN DRY EYE DRUG 2019-2027 ($ MILLION)

FIGURE 31   GLOBAL DRUGS MARKET IN ALLERGIC CONJUNCTIVITIS, INFLAMMATION AND CONJUNCTIVITIS DRUG 2019-2027 ($ MILLION)                              

FIGURE 32   GLOBAL DRUGS BY USE OF PRESERVATION IN PRESERVED DRUGS 2019-2027 ($ MILLION)                           

FIGURE 33   GLOBAL DRUGS BY USE OF PRESERVATION IN PRESERVATIVE-FREE DRUGS 2019-2027 ($ MILLION)                             

FIGURE 34   GLOBAL PRESERVATIVE-FREE DRUGS MARKET IN SINGLE-DOSE 2019-2027 ($ MILLION)                              

FIGURE 35   GLOBAL PRESERVATIVE-FREE DRUGS MARKET IN MULTI-DOSE 2019-2027 ($ MILLION)                              

FIGURE 36   NORTH AMERICA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                         

FIGURE 37   THE UNITED STATES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                           

FIGURE 38   CANADA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 39   EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 40   THE UNITED KINGDOM OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                           

FIGURE 41   FRANCE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 42   GERMANY OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 43   SPAIN OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                                   

FIGURE 44   ITALY OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                                   

FIGURE 45   RUSSIA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 46   REST OF EUROPE OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                         

FIGURE 47   ASIA-PACIFIC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 48   INDIA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                                   

FIGURE 49   CHINA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                                   

FIGURE 50   JAPAN OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                                   

FIGURE 51   SOUTH KOREA OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 52   AUSTRALIA & NEW ZEALAND OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                             

FIGURE 53   ASEAN COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                           

FIGURE 54   REST OF APAC OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 55   BRAZIL OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 56   MEXICO OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                              

FIGURE 57   REST OF LATIN AMERICA COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                                   

FIGURE 58   SAUDI ARABIA COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                             

FIGURE 59   TURKEY COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                           

FIGURE 60   THE UNITED ARAB EMIRATES COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                             

FIGURE 61   SOUTH AFRICA COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)                             

FIGURE 62   REST OF MIDDLE EAST & AFRICA COUNTRIES OPTHALMOLOGY DRUGS AND DEVICES MARKET 2019-2027 ($ MILLION)      

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;